Humana (HUM): Today's Featured Health Services Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Humana ( HUM) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day down 0.4%. By the end of trading, Humana rose $0.98 (1.1%) to $91.57 on average volume. Throughout the day, 1,213,978 shares of Humana exchanged hands as compared to its average daily volume of 1,485,400 shares. The stock ranged in a price between $90.30-$91.61 after having opened the day at $90.98 as compared to the previous trading day's close of $90.59. Other companies within the Health Services industry that increased today were: ImmunoCellular Therapeutics ( IMUC), up 13.0%, Response Genetics ( RGDX), up 9.9%, Derma ( DSCI), up 7.2% and Air Methods ( AIRM), up 4.3%.

Humana Inc., a health care company, offers a range of insurance products, and health and wellness services that incorporate an integrated approach to lifelong well-being. The company operates in three segments: Retail, Employer Group, and Healthcare Services. Humana has a market cap of $14.2 billion and is part of the health care sector. Shares are up 32.0% year to date as of the close of trading on Tuesday. Currently there are 12 analysts that rate Humana a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Humana as a buy. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in stock price during the past year and attractive valuation levels. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the negative front, Organovo Holdings ( ONVO), down 10.3%, Pingtan Marine Enterprise ( PME), down 10.2%, MiMedx Group ( MDXG), down 6.4% and Spherix ( SPEX), down 6.2% , were all laggards within the health services industry with Intuitive Surgical ( ISRG) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Apple Is the Tom Brady of Stocks: Cramer's 'Mad Money' Recap (Thursday 8/31/17)

Boeing, Pure Storage, Activision Blizzard: 'Mad Money' Lightning Round

The Makings of Another Huge Rebound?

Healthcare Management Stocks Look Too Pricey for Activists

Tenet Dives After Worse Than Expected Quarter Leads to Lower 2017 Outlook